Common TitleUW PIC 330
Official Title Impact of Raltegravir (Isentress/MK-0518) - Containing Regimens on HIV-1 Infected CD4+ T-Cells During Acute and Early HIV-1 Infection: A Randomized, Controlled Study Comparing Standard Antiretroviral Therapy to Standard Therapy Plus Raltegravir
Phase Phase IV
ClinicalTrials.gov NCT00781287
Treatments
Raltegravir
Raltegravir
Tradename:IsentressOther Names:RALClass:Integrase Inhibitors (INSTI)Categories Treatment-NaiveAcute HIV
Funding
IndustryMerck Sharp & Dohme Corp
Non-IndustryUniversity of Washington
References
- Collier AC, Chun TW, Maenza J, et al. A Pilot Study of Raltegravir Plus Combination Antiretroviral Therapy in Early Human Immunodeficiency Virus Infection: Challenges and Lessons Learned. Biores Open Access. 2016;5:15-21.